| 29.14 0.54 (1.89%) | 07-26 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 35.52 | 1-year : | 41.49 |
| Resists | First : | 30.41 | Second : | 35.52 |
| Pivot price | 28.44 |
|||
| Supports | First : | 27.19 |
Second : | 25.2 |
| MAs | MA(5) : | 28.28 |
MA(20) : | 28.43 |
| MA(100) : | 30.88  |
MA(250) : | 33.97 |
|
| MACD | MACD : | 0.1 |
Signal : | 0.1 |
| %K %D | K(14,3) : | 46.3 |
D(3) : | 36.8 |
| RSI | RSI(14): 56.4 |
|||
| 52-week | High : | 44.95 | Low : | 23.89 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ PGNY ] has closed below upper band by 26.5%. Bollinger Bands are 36.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 29.32 - 29.44 | 29.44 - 29.55 |
| Low: | 28.47 - 28.61 | 28.61 - 28.73 |
| Close: | 28.93 - 29.14 | 29.14 - 29.33 |
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
Fri, 26 Jul 2024
Janney Montgomery Scott LLC Takes Position in Progyny, Inc. (NASDAQ:PGNY) - Defense World
Tue, 23 Jul 2024
Progyny, Inc. Announces Details for Its Second Quarter 2024 Results Report - StockTitan
Tue, 23 Jul 2024
Russell Investments Group Ltd. Increases Stake in Progyny, Inc. (NASDAQ:PGNY) - Defense World
Sat, 20 Jul 2024
At US$27.79, Is Progyny, Inc. (NASDAQ:PGNY) Worth Looking At Closely? - Simply Wall St
Sat, 20 Jul 2024
Sei Investments Co. Sells 5,281 Shares of Progyny, Inc. (NASDAQ:PGNY) - American Banking and Market News
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 95 (M) |
| Shares Float | 82 (M) |
| Held by Insiders | 6.2 (%) |
| Held by Institutions | 105.2 (%) |
| Shares Short | 7,570 (K) |
| Shares Short P.Month | 7,350 (K) |
| EPS | 0.61 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 5.98 |
| Profit Margin | 5.5 % |
| Operating Margin | 6.6 % |
| Return on Assets (ttm) | 5.6 % |
| Return on Equity (ttm) | 12.3 % |
| Qtrly Rev. Growth | 7.5 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 11.65 |
| EBITDA (p.s.) | 0.71 |
| Qtrly Earnings Growth | -5.6 % |
| Operating Cash Flow | 194 (M) |
| Levered Free Cash Flow | 170 (M) |
| PE Ratio | 47.77 |
| PEG Ratio | 2 |
| Price to Book value | 4.86 |
| Price to Sales | 2.49 |
| Price to Cash Flow | 14.33 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|